A multicenter, open-label, dose-escalation, first-in-man...

Annals of Oncology 2020 / 09 Vol. 31

A multicenter, open-label, dose-escalation, first-in-man study of MetAP2 inhibitor M8891 in patients with advanced solid tumours

Carducci, M.A., Wang, D., Habermehl, C., Bödding, M., Rohdich, F., Stinchi, S., Karpenko, O., Gimmi, C., LoRusso, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.680
Date:
September, 2020
File:
PDF, 73 KB
2020
Conversion to is in progress
Conversion to is failed